GSK3B and Patent ductus arteriosus: In this context, GSK3β has been specifically identified as a negative regulator of TNFα-induced apoptosis in PDA, and GSK3 inhibitors have been reported to reduce PDA progression and apoptosis resistance; however, the contribution of GSK3α is not fully understood.